Concepts (315)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognitive Dysfunction | 28 | 2025 | 695 | 4.600 |
Why?
|
| Healthy Lifestyle | 10 | 2024 | 36 | 3.360 |
Why?
|
| Cardiovascular Diseases | 16 | 2025 | 281 | 3.230 |
Why?
|
| Alzheimer Disease | 13 | 2025 | 1271 | 3.130 |
Why?
|
| Life Expectancy | 9 | 2022 | 22 | 2.360 |
Why?
|
| Diet, Mediterranean | 10 | 2024 | 60 | 2.250 |
Why?
|
| Obesity | 10 | 2020 | 288 | 2.240 |
Why?
|
| Aged | 62 | 2025 | 7300 | 1.920 |
Why?
|
| Body Mass Index | 13 | 2024 | 379 | 1.790 |
Why?
|
| Prospective Studies | 31 | 2025 | 1476 | 1.740 |
Why?
|
| Female | 66 | 2025 | 12734 | 1.670 |
Why?
|
| Risk Factors | 31 | 2025 | 1955 | 1.630 |
Why?
|
| Humans | 91 | 2025 | 22592 | 1.610 |
Why?
|
| Male | 58 | 2025 | 12260 | 1.590 |
Why?
|
| Apolipoprotein E4 | 8 | 2025 | 173 | 1.550 |
Why?
|
| Exercise | 13 | 2022 | 387 | 1.540 |
Why?
|
| Cognition | 15 | 2024 | 915 | 1.420 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2024 | 147 | 1.330 |
Why?
|
| Netherlands | 18 | 2024 | 25 | 1.300 |
Why?
|
| Aging | 11 | 2025 | 1062 | 1.240 |
Why?
|
| Cohort Studies | 21 | 2025 | 1386 | 1.160 |
Why?
|
| Independent Living | 6 | 2025 | 219 | 1.150 |
Why?
|
| Pediatric Obesity | 2 | 2018 | 43 | 1.080 |
Why?
|
| Mothers | 2 | 2018 | 159 | 0.990 |
Why?
|
| Stroke | 5 | 2023 | 236 | 0.980 |
Why?
|
| Neurodegenerative Diseases | 6 | 2025 | 90 | 0.920 |
Why?
|
| Aged, 80 and over | 23 | 2025 | 3657 | 0.890 |
Why?
|
| Chicago | 16 | 2025 | 788 | 0.890 |
Why?
|
| Waist Circumference | 4 | 2016 | 35 | 0.840 |
Why?
|
| Middle Aged | 30 | 2024 | 7800 | 0.840 |
Why?
|
| Dementia | 6 | 2024 | 382 | 0.820 |
Why?
|
| Vitamin D | 2 | 2022 | 27 | 0.800 |
Why?
|
| DNA Methylation | 6 | 2021 | 127 | 0.770 |
Why?
|
| Risk Assessment | 7 | 2024 | 537 | 0.740 |
Why?
|
| Longitudinal Studies | 10 | 2025 | 1038 | 0.730 |
Why?
|
| Overweight | 5 | 2021 | 65 | 0.710 |
Why?
|
| Brain | 6 | 2024 | 1123 | 0.710 |
Why?
|
| Blood Pressure | 3 | 2024 | 165 | 0.700 |
Why?
|
| Epigenomics | 4 | 2021 | 11 | 0.690 |
Why?
|
| Menopause | 5 | 2024 | 99 | 0.670 |
Why?
|
| United States | 9 | 2024 | 1741 | 0.660 |
Why?
|
| Dietary Approaches To Stop Hypertension | 4 | 2024 | 21 | 0.630 |
Why?
|
| Incidence | 9 | 2025 | 618 | 0.600 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2018 | 1 | 0.590 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 19 | 0.580 |
Why?
|
| Mortality | 2 | 2016 | 68 | 0.580 |
Why?
|
| Metabolic Syndrome | 2 | 2016 | 55 | 0.580 |
Why?
|
| Preconception Care | 1 | 2018 | 1 | 0.570 |
Why?
|
| Patient Compliance | 1 | 2018 | 142 | 0.530 |
Why?
|
| Lipids | 3 | 2025 | 45 | 0.530 |
Why?
|
| Biomarkers | 8 | 2025 | 455 | 0.530 |
Why?
|
| Proportional Hazards Models | 8 | 2024 | 269 | 0.510 |
Why?
|
| Neurofilament Proteins | 3 | 2025 | 14 | 0.510 |
Why?
|
| Life Style | 4 | 2022 | 157 | 0.510 |
Why?
|
| Obesity, Metabolically Benign | 1 | 2016 | 1 | 0.500 |
Why?
|
| tau Proteins | 3 | 2025 | 141 | 0.480 |
Why?
|
| Body Composition | 1 | 2016 | 64 | 0.480 |
Why?
|
| Anthropometry | 1 | 2015 | 28 | 0.470 |
Why?
|
| Alleles | 4 | 2024 | 162 | 0.470 |
Why?
|
| Somatotypes | 1 | 2014 | 2 | 0.460 |
Why?
|
| Follow-Up Studies | 5 | 2024 | 1403 | 0.450 |
Why?
|
| Genome-Wide Association Study | 5 | 2022 | 145 | 0.390 |
Why?
|
| Adult | 11 | 2024 | 6826 | 0.380 |
Why?
|
| Postmenopause | 3 | 2018 | 57 | 0.370 |
Why?
|
| Carotid Intima-Media Thickness | 3 | 2022 | 17 | 0.370 |
Why?
|
| Diet | 5 | 2024 | 178 | 0.370 |
Why?
|
| Risk Reduction Behavior | 4 | 2020 | 36 | 0.370 |
Why?
|
| Environmental Exposure | 2 | 2024 | 18 | 0.360 |
Why?
|
| White Matter | 2 | 2022 | 86 | 0.360 |
Why?
|
| Air Pollution | 2 | 2024 | 14 | 0.350 |
Why?
|
| Alcohol Drinking | 4 | 2020 | 66 | 0.350 |
Why?
|
| CpG Islands | 4 | 2021 | 43 | 0.350 |
Why?
|
| Atherosclerosis | 3 | 2022 | 44 | 0.350 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2021 | 261 | 0.330 |
Why?
|
| Surveys and Questionnaires | 5 | 2024 | 1019 | 0.320 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 76 | 0.300 |
Why?
|
| Apolipoproteins E | 4 | 2023 | 141 | 0.300 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 79 | 0.300 |
Why?
|
| Pandemics | 2 | 2020 | 198 | 0.300 |
Why?
|
| Population Surveillance | 2 | 2021 | 100 | 0.290 |
Why?
|
| Intermediate Filaments | 3 | 2023 | 18 | 0.280 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2025 | 36 | 0.280 |
Why?
|
| Coronary Disease | 2 | 2018 | 47 | 0.280 |
Why?
|
| Body Size | 2 | 2019 | 6 | 0.280 |
Why?
|
| Adolescent | 4 | 2024 | 1855 | 0.280 |
Why?
|
| Dietary Supplements | 3 | 2022 | 54 | 0.270 |
Why?
|
| Lipid Metabolism | 2 | 2017 | 32 | 0.260 |
Why?
|
| Child | 3 | 2024 | 1148 | 0.260 |
Why?
|
| Prevalence | 3 | 2023 | 372 | 0.250 |
Why?
|
| Estrogen Receptor beta | 2 | 2016 | 4 | 0.250 |
Why?
|
| Amyloid beta-Peptides | 2 | 2024 | 194 | 0.240 |
Why?
|
| Sex Factors | 5 | 2020 | 380 | 0.240 |
Why?
|
| Epigenesis, Genetic | 4 | 2021 | 61 | 0.240 |
Why?
|
| Waist-Hip Ratio | 2 | 2015 | 12 | 0.230 |
Why?
|
| Coronary Artery Disease | 2 | 2017 | 123 | 0.230 |
Why?
|
| Coffee | 1 | 2024 | 3 | 0.230 |
Why?
|
| Vehicle Emissions | 1 | 2024 | 5 | 0.230 |
Why?
|
| Social Isolation | 1 | 2025 | 19 | 0.230 |
Why?
|
| Beverages | 1 | 2024 | 12 | 0.220 |
Why?
|
| Air Pollutants | 1 | 2024 | 11 | 0.220 |
Why?
|
| Particulate Matter | 1 | 2024 | 16 | 0.220 |
Why?
|
| Loneliness | 1 | 2025 | 42 | 0.220 |
Why?
|
| Weight Gain | 3 | 2024 | 59 | 0.210 |
Why?
|
| Dietary Fats | 1 | 2024 | 38 | 0.210 |
Why?
|
| Memory Disorders | 1 | 2024 | 104 | 0.210 |
Why?
|
| Whole Grains | 1 | 2023 | 4 | 0.210 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 164 | 0.210 |
Why?
|
| Florida | 1 | 2023 | 15 | 0.210 |
Why?
|
| Flavonols | 1 | 2022 | 5 | 0.200 |
Why?
|
| Time Factors | 7 | 2021 | 1247 | 0.200 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2022 | 2 | 0.200 |
Why?
|
| Vitamin E | 1 | 2023 | 37 | 0.200 |
Why?
|
| Betacoronavirus | 2 | 2020 | 66 | 0.190 |
Why?
|
| Vitamins | 1 | 2022 | 14 | 0.190 |
Why?
|
| Comorbidity | 3 | 2022 | 423 | 0.190 |
Why?
|
| Smoking | 3 | 2020 | 161 | 0.190 |
Why?
|
| Gastrointestinal Diseases | 1 | 2022 | 24 | 0.180 |
Why?
|
| Lutein | 1 | 2021 | 3 | 0.180 |
Why?
|
| Zeaxanthins | 1 | 2021 | 3 | 0.180 |
Why?
|
| Carotenoids | 1 | 2021 | 14 | 0.180 |
Why?
|
| Survivors | 1 | 2022 | 69 | 0.180 |
Why?
|
| Diet Surveys | 1 | 2021 | 23 | 0.180 |
Why?
|
| Lipoproteins, HDL | 1 | 2021 | 23 | 0.180 |
Why?
|
| Leukocytes | 1 | 2021 | 30 | 0.180 |
Why?
|
| Health Status | 2 | 2019 | 201 | 0.180 |
Why?
|
| Neuropsychological Tests | 2 | 2021 | 847 | 0.180 |
Why?
|
| Nurses | 2 | 2018 | 41 | 0.170 |
Why?
|
| Diet, Western | 1 | 2021 | 7 | 0.170 |
Why?
|
| Amyloid | 1 | 2021 | 38 | 0.170 |
Why?
|
| Body Weight | 2 | 2018 | 129 | 0.170 |
Why?
|
| Weight Loss | 2 | 2020 | 121 | 0.170 |
Why?
|
| Eczema | 1 | 2020 | 3 | 0.170 |
Why?
|
| Lipase | 1 | 2020 | 4 | 0.170 |
Why?
|
| Phenotype | 2 | 2018 | 255 | 0.170 |
Why?
|
| Membrane Proteins | 1 | 2021 | 151 | 0.170 |
Why?
|
| Rhinitis, Allergic | 1 | 2020 | 13 | 0.170 |
Why?
|
| Dyslipidemias | 2 | 2019 | 13 | 0.170 |
Why?
|
| Geriatric Assessment | 1 | 2021 | 159 | 0.170 |
Why?
|
| Diabetes Mellitus | 2 | 2019 | 101 | 0.160 |
Why?
|
| Pancreas | 1 | 2020 | 30 | 0.160 |
Why?
|
| Food Hypersensitivity | 1 | 2020 | 40 | 0.160 |
Why?
|
| Neoplasms | 2 | 2020 | 216 | 0.160 |
Why?
|
| Autopsy | 1 | 2021 | 249 | 0.160 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2018 | 16 | 0.160 |
Why?
|
| Inbreeding Depression | 1 | 2019 | 1 | 0.160 |
Why?
|
| Consanguinity | 1 | 2019 | 2 | 0.160 |
Why?
|
| Fertility | 1 | 2019 | 17 | 0.160 |
Why?
|
| Cholesterol, HDL | 2 | 2016 | 26 | 0.160 |
Why?
|
| Risk-Taking | 1 | 2019 | 27 | 0.160 |
Why?
|
| Socioeconomic Factors | 2 | 2019 | 244 | 0.150 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2019 | 30 | 0.150 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 32 | 0.150 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2018 | 4 | 0.150 |
Why?
|
| Antioxidants | 1 | 2018 | 56 | 0.140 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 432 | 0.140 |
Why?
|
| Asthma | 1 | 2020 | 149 | 0.140 |
Why?
|
| Insulin Resistance | 2 | 2017 | 47 | 0.140 |
Why?
|
| Androgens | 1 | 2018 | 7 | 0.140 |
Why?
|
| Lung Diseases | 1 | 2018 | 36 | 0.140 |
Why?
|
| Mother-Child Relations | 1 | 2018 | 27 | 0.140 |
Why?
|
| Endocrine Disruptors | 1 | 2018 | 1 | 0.140 |
Why?
|
| Child Behavior | 1 | 2018 | 28 | 0.140 |
Why?
|
| Basal Metabolism | 1 | 2018 | 7 | 0.140 |
Why?
|
| Fluorocarbons | 1 | 2018 | 11 | 0.140 |
Why?
|
| Testosterone | 1 | 2018 | 27 | 0.140 |
Why?
|
| Diet, Reducing | 1 | 2018 | 12 | 0.140 |
Why?
|
| Hospitalization | 1 | 2020 | 281 | 0.140 |
Why?
|
| Thiocyanates | 1 | 2017 | 4 | 0.140 |
Why?
|
| Perchlorates | 1 | 2017 | 5 | 0.140 |
Why?
|
| Nitrates | 1 | 2017 | 9 | 0.140 |
Why?
|
| Thyroid Function Tests | 1 | 2017 | 12 | 0.140 |
Why?
|
| Health Personnel | 1 | 2018 | 80 | 0.140 |
Why?
|
| Vascular Calcification | 1 | 2017 | 9 | 0.140 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2017 | 1 | 0.140 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2017 | 1 | 0.140 |
Why?
|
| Aspartate Aminotransferases | 1 | 2017 | 13 | 0.130 |
Why?
|
| Protective Factors | 4 | 2018 | 20 | 0.130 |
Why?
|
| Alanine Transaminase | 1 | 2017 | 15 | 0.130 |
Why?
|
| Cognition Disorders | 1 | 2022 | 681 | 0.130 |
Why?
|
| Fatty Liver | 1 | 2017 | 26 | 0.130 |
Why?
|
| Pregnancy | 1 | 2018 | 308 | 0.130 |
Why?
|
| Transportation | 1 | 2016 | 4 | 0.130 |
Why?
|
| Inhalation Exposure | 1 | 2016 | 5 | 0.130 |
Why?
|
| Histones | 1 | 2016 | 28 | 0.130 |
Why?
|
| Actigraphy | 1 | 2016 | 78 | 0.130 |
Why?
|
| Primary Prevention | 1 | 2016 | 22 | 0.130 |
Why?
|
| Case-Control Studies | 1 | 2017 | 477 | 0.130 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2016 | 5 | 0.130 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2016 | 9 | 0.130 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 752 | 0.120 |
Why?
|
| Child, Preschool | 1 | 2018 | 561 | 0.120 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 40 | 0.120 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2016 | 7 | 0.120 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2016 | 6 | 0.120 |
Why?
|
| Waist-Height Ratio | 1 | 2015 | 5 | 0.120 |
Why?
|
| Adipose Tissue | 1 | 2016 | 72 | 0.120 |
Why?
|
| Cause of Death | 3 | 2022 | 49 | 0.120 |
Why?
|
| Health Behavior | 1 | 2016 | 136 | 0.110 |
Why?
|
| Sweating | 1 | 2014 | 2 | 0.110 |
Why?
|
| Hot Flashes | 1 | 2014 | 11 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 228 | 0.110 |
Why?
|
| Perimenopause | 1 | 2014 | 14 | 0.110 |
Why?
|
| Copper | 2 | 2024 | 14 | 0.110 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 431 | 0.100 |
Why?
|
| Risk | 3 | 2018 | 158 | 0.100 |
Why?
|
| Prognosis | 1 | 2015 | 719 | 0.100 |
Why?
|
| Age Factors | 3 | 2022 | 623 | 0.100 |
Why?
|
| Multivariate Analysis | 3 | 2018 | 282 | 0.100 |
Why?
|
| Triglycerides | 2 | 2025 | 53 | 0.090 |
Why?
|
| Cholesterol | 2 | 2025 | 52 | 0.090 |
Why?
|
| Genotype | 2 | 2024 | 246 | 0.090 |
Why?
|
| Quantitative Trait Loci | 2 | 2021 | 25 | 0.080 |
Why?
|
| Carnitine O-Palmitoyltransferase | 2 | 2021 | 2 | 0.080 |
Why?
|
| Educational Status | 2 | 2021 | 209 | 0.080 |
Why?
|
| Nutrition Surveys | 2 | 2018 | 21 | 0.070 |
Why?
|
| Walking | 2 | 2021 | 233 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2016 | 242 | 0.060 |
Why?
|
| Switzerland | 1 | 2024 | 8 | 0.060 |
Why?
|
| Nitrogen Dioxide | 1 | 2024 | 4 | 0.060 |
Why?
|
| Nitrogen Oxides | 1 | 2024 | 4 | 0.060 |
Why?
|
| Tea | 1 | 2024 | 4 | 0.060 |
Why?
|
| Bayes Theorem | 1 | 2024 | 32 | 0.060 |
Why?
|
| Food Handling | 1 | 2024 | 2 | 0.060 |
Why?
|
| Fast Foods | 1 | 2024 | 5 | 0.060 |
Why?
|
| Heterozygote | 1 | 2025 | 89 | 0.060 |
Why?
|
| Zinc | 1 | 2024 | 39 | 0.060 |
Why?
|
| Energy Intake | 1 | 2024 | 77 | 0.050 |
Why?
|
| Feeding Behavior | 1 | 2024 | 78 | 0.050 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2023 | 6 | 0.050 |
Why?
|
| Caloric Restriction | 1 | 2023 | 10 | 0.050 |
Why?
|
| Hypertension | 1 | 2024 | 160 | 0.050 |
Why?
|
| Tocopherols | 1 | 2023 | 8 | 0.050 |
Why?
|
| alpha-Tocopherol | 1 | 2023 | 11 | 0.050 |
Why?
|
| Quercetin | 1 | 2022 | 5 | 0.050 |
Why?
|
| Kaempferols | 1 | 2022 | 6 | 0.050 |
Why?
|
| Diet, Vegetarian | 1 | 2022 | 5 | 0.050 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2022 | 22 | 0.050 |
Why?
|
| Brain Infarction | 1 | 2023 | 63 | 0.050 |
Why?
|
| Eating | 1 | 2022 | 45 | 0.050 |
Why?
|
| Memory, Short-Term | 1 | 2022 | 79 | 0.050 |
Why?
|
| Biological Specimen Banks | 1 | 2022 | 5 | 0.050 |
Why?
|
| United Kingdom | 1 | 2022 | 27 | 0.050 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2022 | 41 | 0.050 |
Why?
|
| Vegetables | 1 | 2021 | 20 | 0.050 |
Why?
|
| Gene Expression | 1 | 2022 | 174 | 0.040 |
Why?
|
| Accelerometry | 1 | 2021 | 77 | 0.040 |
Why?
|
| Executive Function | 1 | 2021 | 86 | 0.040 |
Why?
|
| Music Therapy | 1 | 2020 | 2 | 0.040 |
Why?
|
| Intubation | 1 | 2020 | 5 | 0.040 |
Why?
|
| Meditation | 1 | 2020 | 21 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2020 | 17 | 0.040 |
Why?
|
| Homozygote | 1 | 2019 | 13 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 68 | 0.040 |
Why?
|
| Haplotypes | 1 | 2019 | 41 | 0.040 |
Why?
|
| Nursing Research | 1 | 2020 | 33 | 0.040 |
Why?
|
| Disease Management | 1 | 2020 | 99 | 0.040 |
Why?
|
| Diastole | 1 | 2019 | 28 | 0.040 |
Why?
|
| ADAMTS9 Protein | 1 | 2018 | 1 | 0.040 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2018 | 2 | 0.040 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 2018 | 2 | 0.040 |
Why?
|
| Lod Score | 1 | 2018 | 11 | 0.040 |
Why?
|
| Animals | 2 | 2016 | 3238 | 0.040 |
Why?
|
| Age of Onset | 1 | 2019 | 71 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2019 | 99 | 0.040 |
Why?
|
| Dehydroepiandrosterone | 1 | 2018 | 4 | 0.040 |
Why?
|
| Androstenedione | 1 | 2018 | 6 | 0.040 |
Why?
|
| Rest | 1 | 2018 | 27 | 0.040 |
Why?
|
| Symporters | 1 | 2017 | 5 | 0.030 |
Why?
|
| Life Tables | 1 | 2017 | 4 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 189 | 0.030 |
Why?
|
| Amino Acid Transport System ASC | 1 | 2017 | 1 | 0.030 |
Why?
|
| Amino Acid Transport System y+L | 1 | 2017 | 1 | 0.030 |
Why?
|
| Phosphoglycerate Dehydrogenase | 1 | 2017 | 1 | 0.030 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2017 | 3 | 0.030 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2017 | 5 | 0.030 |
Why?
|
| RNA Interference | 1 | 2017 | 36 | 0.030 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2017 | 1 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 50 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2017 | 2 | 0.030 |
Why?
|
| Transfection | 1 | 2017 | 119 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 800 | 0.030 |
Why?
|
| Histone Code | 1 | 2016 | 1 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 300 | 0.030 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2016 | 2 | 0.030 |
Why?
|
| Bias | 1 | 2016 | 23 | 0.030 |
Why?
|
| Logistic Models | 1 | 2017 | 350 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2016 | 27 | 0.030 |
Why?
|
| Genome, Human | 1 | 2016 | 33 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 217 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 45 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 242 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2016 | 49 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 165 | 0.030 |
Why?
|
| Health | 1 | 2016 | 9 | 0.030 |
Why?
|
| Gardening | 1 | 2016 | 1 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2016 | 87 | 0.030 |
Why?
|
| Bicycling | 1 | 2016 | 4 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 126 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2016 | 131 | 0.030 |
Why?
|
| Arteries | 1 | 2016 | 13 | 0.030 |
Why?
|
| Sports | 1 | 2016 | 28 | 0.030 |
Why?
|
| Cardiology | 1 | 2016 | 45 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 2016 | 51 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2016 | 71 | 0.030 |
Why?
|
| Cell Movement | 1 | 2016 | 77 | 0.030 |
Why?
|
| Anxiety | 1 | 2016 | 143 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2016 | 164 | 0.030 |
Why?
|
| Calcium | 1 | 2018 | 355 | 0.030 |
Why?
|
| Inflammation | 1 | 2016 | 223 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 2016 | 163 | 0.030 |
Why?
|
| Vasomotor System | 1 | 2014 | 3 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 574 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2016 | 393 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2020 | 2915 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2016 | 586 | 0.020 |
Why?
|